224 related articles for article (PubMed ID: 28630196)
1. Antimicrobial Susceptibility Trends among Staphylococcus aureus Isolates from U.S. Hospitals: Results from 7 Years of the Ceftaroline (AWARE) Surveillance Program, 2010 to 2016.
Sader HS; Mendes RE; Streit JM; Flamm RK
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630196
[TBL] [Abstract][Full Text] [Related]
2. Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
Richter SS; Heilmann KP; Dohrn CL; Riahi F; Costello AJ; Kroeger JS; Biek D; Critchley IA; Diekema DJ; Doern GV
Antimicrob Agents Chemother; 2011 Sep; 55(9):4154-60. PubMed ID: 21709080
[TBL] [Abstract][Full Text] [Related]
3. Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program.
Sader HS; Flamm RK; Farrell DJ; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S181-6. PubMed ID: 22903950
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers.
Sader HS; Farrell DJ; Flamm RK; Jones RN
Surg Infect (Larchmt); 2016 Aug; 17(4):443-7. PubMed ID: 26990170
[TBL] [Abstract][Full Text] [Related]
5. In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.
Kanayama S; Ikeda F; Okamoto K; Nakajima A; Matsumoto T; Ishii R; Amano A; Matsuzaki K; Matsumoto S
J Infect Chemother; 2016 Oct; 22(10):720-3. PubMed ID: 27091753
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility patterns of community- and hospital-acquired methicillin-resistant Staphylococcus aureus from United States Hospitals: results from the AWARE Ceftaroline Surveillance Program (2012-2014).
Sader HS; Mendes RE; Jones RN; Flamm RK
Diagn Microbiol Infect Dis; 2016 Sep; 86(1):76-9. PubMed ID: 27394637
[TBL] [Abstract][Full Text] [Related]
7. Impact of EUCAST ceftaroline breakpoint change on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from patients with complicated skin and soft-tissue infections.
Urbán E; Stone GG
Clin Microbiol Infect; 2019 Nov; 25(11):1429.e1-1429.e4. PubMed ID: 30980925
[TBL] [Abstract][Full Text] [Related]
8. Activity of ceftaroline and comparator agents tested against Staphylococcus aureus from patients with bloodstream infections in US medical centres (2009-13).
Sader HS; Farrell DJ; Flamm RK; Jones RN
J Antimicrob Chemother; 2015 Jul; 70(7):2053-6. PubMed ID: 25814163
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program.
Biedenbach DJ; Alm RA; Lahiri SD; Reiszner E; Hoban DJ; Sahm DF; Bouchillon SK; Ambler JE
Antimicrob Agents Chemother; 2016 Jan; 60(1):343-7. PubMed ID: 26503659
[TBL] [Abstract][Full Text] [Related]
10. A multicentre study of meticillin-resistant Staphylococcus aureus in acute bacterial skin and skin-structure infections in China: susceptibility to ceftaroline and molecular epidemiology.
Zhang H; Xiao M; Kong F; O'Sullivan MV; Mao LL; Zhao HR; Zhao Y; Wang H; Xu YC
Int J Antimicrob Agents; 2015 Apr; 45(4):347-50. PubMed ID: 25649348
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of dalbavancin and comparators against Staphylococcus aureus causing pneumonia in patients with and without cystic fibrosis.
Sader HS; Duncan LR; Mendes RE
Int J Infect Dis; 2021 Jun; 107():69-71. PubMed ID: 33878463
[TBL] [Abstract][Full Text] [Related]
12.
Schulte RH; Munson E
Clin Med Res; 2019 Dec; 17(3-4):72-81. PubMed ID: 31582419
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial resistance profile of methicillin-resistant
Wu X; Wang C; He L; Xu H; Jing C; Chen Y; Lin A; Deng J; Cao Q; Deng H; Cai H; Chen Y; Yang J; Zhang T; Huang Y; Hao J; Yu H
Front Cell Infect Microbiol; 2023; 13():1102779. PubMed ID: 36743309
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolates Collected in 2012 from Latin American Countries as Part of the AWARE Surveillance Program.
Biedenbach DJ; Hoban DJ; Reiszner E; Lahiri SD; Alm RA; Sahm DF; Bouchillon SK; Ambler JE
Antimicrob Agents Chemother; 2015 Dec; 59(12):7873-7. PubMed ID: 26416860
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
Sader HS; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2013 May; 76(1):61-8. PubMed ID: 23535208
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
[TBL] [Abstract][Full Text] [Related]
17. Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals: 2012-2014.
Pfaller MA; Mendes RE; Castanheira M; Flamm RK; Jones RN; Sader HS
Pediatr Infect Dis J; 2017 May; 36(5):486-491. PubMed ID: 28403050
[TBL] [Abstract][Full Text] [Related]
18. Nasal carriage of methicillin resistant Staphylococcus aureus and their antibiotic susceptibility patterns in children attending day-care centers.
Sedighi I; Moez HJ; Alikhani MY
Acta Microbiol Immunol Hung; 2011 Sep; 58(3):227-34. PubMed ID: 21983324
[TBL] [Abstract][Full Text] [Related]
19. Antibiogram testing of pediatric skin infections in the era of methicillin-resistant Staphylococci aureus: an Egyptian University Hospital-based study.
Abdel Fattah NS; Darwish YW
Int J Dermatol; 2012 Dec; 51(12):1441-7. PubMed ID: 22928620
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum β-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018 and Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2018-2019.
Jean SS; Ko WC; Hsueh PR;
Int J Antimicrob Agents; 2020 Jul; 56(1):106016. PubMed ID: 32422316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
